by nmgarcia | Dec 13, 2021 | In the Press
Click here for the full video of Dr. Rubin detailing his 8-point strategy for steps the gastroenterology community should take to prepare for another pandemic in the future to ensure the best outcomes for patients and conditions for professionals.
by nmgarcia | Nov 9, 2021 | In the Press
A newly discovered vascular brain barrier that blocks the passage of inflammatory molecules triggered by gut bacteria may be why patients with inflammatory bowel disease (IBD) are at increased risk for certain mental health disorders, including anxiety and depression,...
by nmgarcia | Nov 5, 2021 | In the Press
Click here for the full video of Dr. Rubin reviewing his presentation from the American College of Gastroenterology Scientific Meeting on therapeutic drug monitoring (TDM), including the appropriate application of proactive TDM in the treatment of inflammatory bowel...
by David Rubin | Oct 12, 2021 | In the Press
“The findings did not surprise us, but supported our hypothesis that patients with UC have reduced compliance of their rectum, even when they are in remission,” Dr. Rubin told Reuters Health by email. “The exciting new finding is that those who...
by David Rubin | Aug 6, 2021 | In the Press
Click here to listen to Dr. Rubin speak with colleagues and IBD Drive Time hosts Raymond Cross, MD and Millie Long, MD on using newly-approved ozanimod in treating ulcerative colitis.
by tinar | Jun 7, 2021 | In the Press
Click here for the full video discussing the use of COVID-19 vaccines to prevent COVID-19 infections in patients with inflammatory bowel disease.
